Skip to main content
Premium Trial:

Request an Annual Quote

Illumina's Public Stock Offering Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Aug. 15.
 
1. Illumina Nets $340M in Public Offering (from Aug. 13)
 
2. Nanogen to Merge with French Dx Firm Elitech in Reverse Acquisition (from Aug. 14)
 
3. JGI's Rubin Predicts Genomics Will Spur Biofuel Development (from Aug. 13)
 
4. FDA Clears Gen-Probe's HBV Assay; Approval Triggers $10M Milestone Payment (from Aug. 14)
 
5. DNA Barcoding Helps Expose Wasp Diversity (from Aug. 12)
The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more